Corneal epithelial MT1-MMP inhibits vascular endothelial cell proliferation and migration

Cornea

Volumn 29, Issue 3, 2010, Pages 321-330

  Azar, Dimitri T ^a,b,c   Casanova, Fabio H ^b,c   Mimura, Tatsuya ^a,b   Jain, Sandeep ^a,c   Zhou, Zhongjun ^d   Han, Kyu Yeon ^a   Chang, Jin Hong ^a,b,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cornea; Epithelium; MT1 MMP; TIMP

Indexed keywords

DNA; MATRIX METALLOPROTEINASE 14; RETROVIRUS VECTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CORNEA EPITHELIUM; DNA SYNTHESIS; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VIRUS RECOMBINANT; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANIMALS; BLOTTING, WESTERN; CATTLE; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, VASCULAR; EPITHELIUM, CORNEAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MATRIX METALLOPROTEINASE 14; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PLASMIDS; PULMONARY ARTERY; RETROVIRIDAE; TRANSFECTION;

EID: 77649164902     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181b1165d     Document Type: Article

References (34)

1. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997;91:439-442.
2. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994;370:61-65.
3. Coussens LM, Jacks T. Genetic and cellular mechanisms of oncogenesis. Curr Opin Genet Dev. 2008;18:1-2.
4. Rooprai HK, Van Meter T, Rucklidge GJ, et al. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochem-istry and zymography in human primary brain tumours. Int J Oncol. 1998; 13:1153-1157.
5. Williamson RA, Hutton M, Vogt G, et al. Tyrosine 36 plays a critical role in the interaction of the AB loop of tissue inhibitor of metalloproteinases-2 with matrix metalloproteinase-14. J Biol Chem. 2001;276:32966-32970.
6. Zhou Z, Apte SS, Soininen R, et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metal-loproteinase I. Proc Natl Acad Sci U S A. 2000;97:4052-4057.
7. Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:264-302.
8. Maharaj AS, D'Amore PA. Roles for VEGF in the adult. Microvasc Res. 2007;74:100-113.
9. D'Amore PA. Vascular endothelial cell growth factor-a: not just for endothelial cells anymore. Am J Pathol. 2007;171:14-18.
10. Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443:993-997.
11. Cursiefen C, Chen L, Saint-Geniez M, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A. 2006;103:11405-11410.
12. Gabison E, Chang JH, Hernandez-Quintela E, et al. Antiangiogenic role of angiostatin during corneal wound healing. Exp Eye Res. 2004;78: 579-589.
13. Chang JH, Javier JA, Chang GY, et al. Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett. 2005;579:3601-3606.
14. Kure T, Chang JH, Kato T, et al. Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol Vis Sci. 2003;44:137-144.
15. Ye HQ, Maeda M, Yu FS, et al. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci. 2000;41:2894-2899.
16. Azar DT, Casanova FH, Mimura T, et al. Effect of MT1-MMP deficiency and overexpression in corneal keratocytes on vascular endothelial cell migration and proliferation. Curr Eye Res. 2008;33:954-962.
17. Kojima T, Chang JH, Azar DT. Proangiogenic role of ephrinB1/EphB1 in basic fibroblast growth factor-induced corneal angiogenesis. Am J Pathol. 2007;170:764-773.
18. Kanayama S, Nishida K, Yamato M, et al. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets invitro. Exp Eye Res. 2007;85:772-781.
19. Pollina EA, Legesse-Miller A, Haley EM, et al. Regulating the angiogenic balance in tissues. Cell Cycle. 2008;7:2056-2070.
20. Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol. 2002;14:624-632.
21. Jiang A, Pei D. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated pro-MMP-2 activation and collagenolysis. J Biol Chem. 2003;278:38765-38771.
22. Jiang A, Lehti K, Wang X, et al. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci U S A. 2001;98:13693-13698.
23. Itoh Y, Ito N, Nagase H, et al. The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface. J Biol Chem. 2008;283:13053-13062.
24. Lehti K, Lohi J, Juntunen MM, et al. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem. 2002;277:8440-8448.
25. Rozanov DV, Deryugina EI, Ratnikov BI, et al. Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem. 2001;276: 25705-25714.
26. Beaujouin M, Liaudet-Coopman E. Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity. Adv Exp Med Biol. 2008;617:453-461.
27. Onguchi T, Han KY, Chang JH, et al. Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am J Pathol. 2009;174:1564-1571.
28. Mimura T, Onguchi T, Chang JH, et al. MT1-MMP-mediated cleavage of decorin in corneal angiogenesis. Am J Pathol. 2009;174:1564-1571.
29. Ghajar CM, George SC, Putnam AJ. Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr. 2008;18: 251-278.
30. Langlois S, Nyalendo C, Di Tomasso G, et al. Membrane-type 1 matrix metalloproteinase stimulates cell migration through epidermal growth factor receptor transactivation. Mol Cancer Res. 2007;5:569-583.
31. Raza SL, Cornelius LA. Matrix metalloproteinases: pro- and antiangio-genic activities. J Investig Dermatol Symp Proc. 2000;5:47-54.
32. Lamoreaux WJ, Fitzgerald ME, Reiner A, et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res. 1998;55:29-42.
33. Reed MJ, Koike T, Sadoun E, et al. Inhibition of TIMP1 enhances angio-genesis in vivo and cell migration in vitro. Microvasc Res. 2003;65:9-17.
34. Gallery ED, Campbell S, Arkell J, et al. Preeclamptic decidual micro-vascular endothelial cells express lower levels of matrix metalloproteinase-1 than normals. Microvasc Res. 1999;57:340-346.